Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients, International Journal of Nephrology and Renovascular Disease, February 2016, Dove Medical Press,
DOI: 10.2147/ijnrd.s96027.
You can read the full text:
Contributors
The following have contributed to this page
